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The objective of this thesis is to assess how the presence of a basic moiety 
would influence the physicochemical profile of chalcones, and to determine if this 
would in turn affect the biological activity of the compounds. To this end, a library of 
chalcones bearing basic functionalities (piperidinyl, piperazinyl, pyridinyl) were 
synthesized by the base-catalyzed Claisen-Schmidt condensation and evaluated for 
the following activities (i) antiproliferative activity against the human breast cancer 
(MCF-7) and colon cancer (HCT 116) cell lines, (ii) antibacterial activity against 
Gram-positive drug sensitive Staphylococcus aureus and Gram-negative Escherichia 
coli, and (iii) inhibition of drug efflux transporters P-glycoprotein (Pgp, ABCB1) and 
breast cancer resistance protein (BCRP, ABCG2) of the ATP binding cassette (ABC) 
family of proteins. The compounds were classified into groups (Groups 1-11) based 
on the substitution pattern on ring A. 
Characterization of the library by steric, lipophilic, hydrogen (H) bonding, 
electronic and topological parameters revealed that basic chalcones had larger polar 
volumes than their non-basic analogues. When the basic group was present on ring B, 
it reduced the positive charge on the β carbon and led to lower HOMO energies 
(poorer electron donating capability). These differences were found to influence the 
antiproliferative activities of the compounds. Analysis of structure activity 
relationships by projection methods (principal component analysis and partial least 
squares projection to latent structures PLS) and multiple linear regression showed that 
good activity was associated with large polar volumes, the absence of hydrogen 
bonding features, low HOMO energies and reduced charge on the β carbon. A basic 
group on either ring A or B of the chalcone led to a favourable increase in polar 
 viii
volume, but when present on ring B, caused HOMO energies to increase and 
diminished the positive charge on the β carbon, both of which led to lower activity. 
Several examples showed that final activity of the chalcone was influenced by 
compensatory interactions among the critical variables. In general, chalcones with a 
single basic functionality had better antiproliferative activities than those with more 
than one basic group. It was also preferable to locate the basic entity on ring A than 
on ring B. In spite of these generalizations, the most promising compound in the 
library was a dibasic chalcone ((E)-1-(2’,4’-dimethoxy-5’-(1’’-methylpiperidin-4’’-
yl)phenyl)-3-(4’-(4’’-methylpiperazin-1’’-yl)phenyl)prop-2-en-1-one, 1-123) which 
had 1-methylpiperidin-1-yl on ring A and 4-methylpiperazin-1-yl on ring B. 
There was some indication that structural differences in the chalcones 
influenced the mode of antiproliferative activity. Monobasic chalcones characterized 
by a single basic entity on ring A, arrested the cell cycle at either G1 or G1 and G2/M 
phases. On the other hand, compound 1-123 with two basic groups did not interfere 
with the cell cycle. Thus a different mechanism accounted for its good 
antiproliferative activity. 
In general, the basic chalcones had rather poor antibacterial activity against S. 
aureus. The most promising compounds ((E)-1-(2’-hydroxy-4’,6’-dimethoxy-3’-(1’’-
methylpiperidin-4’’-yl)phenyl)-3-(4’-methylphenyl)prop-2-en-1-one, 2-52; and (E)-3-
(3’-chlorophenyl)-1-(2’-hydroxy-4’,6’-dimethoxy-3’-(1’’-methylpiperidin-4’’-
yl)phenyl)prop-2-en-1-one, 2-57) had comparable antibacterial activities (MIC 6.3 
µM, S. aureus) to licochalcone A. In addition, both compounds caused limited 
hemolysis of erythrocytes at 100 µM. SAR showed that the joint presence of the 
phenolic OH and basic 1-methylpiperidinyl ring, characteristic of the ring A in Group 
2, was important for activity. Omission of either or both groups caused a marked 
 ix
reduction in antibacterial activity. Similar to the structural requirements for 
antiproliferative activity, the preferred location of the basic heterocycle was ring A 
and introducing another basic group on ring B resulted in less or no activity. The 
compounds from different Groups with varying MIC values caused negligible 
hemolysis of erythrocytes even at 100 µM, which suggested that the structural 
requirements associated with restriction of hemolytic activity were less stringent that 
those for antibacterial activity. 
Of the three biological activities considered in this study, the unique role of 
the basic functionality was most clearly shown in their inhibition of drug efflux 
transporters Pgp and BCRP. Several basic chalcones inhibited Pgp efflux activity at 
10 µM, as seen from their effects on calcein-AM accumulation in MDCKII/MDR1 
cells. Three compounds from Group 6 which had ring A substituted with 5-(1’-
ethylpiperidin-4’-yl) and 2,4-dimethoxy groups were found to increase calcein-AM 
accumulation to a greater extent than verapamil, a Pgp inhibitor. These compounds 
were subsequently shown to enhance the uptake of doxorubicin by MCF-7 cells that 
were drug selected for over-expression of Pgp. SAR showed that the basic group was 
a necessary but not sufficient feature for inhibitory activity. The presence of the meta-
dimethoxy motif on the chalcone framework was required, presumably because they 
introduced electron donor atoms with optimal spatial distances postulated to be 
important for activity. Lipophilicity was not found to be a critical determinant of 
activity. 
When tested for inhibition of BCRP by the mitoxantrone uptake assay, the 
basic chalcones with good Pgp inhibitory activity fared poorly. A general trend was 
that the basic chalcones were better inhibitors of Pgp than BCRP. In contrast, non-
basic chalcones were better inhibitors of BCRP than Pgp. However, these 
 x
observations were made on a limited number of compounds and would need further 
confirmation. In spite of the differing structural requirements for Pgp and BCRP 
inhibition, chalcone 3-100 ((E)-3-(2’,4’-dimethoxyphenyl)-1-(4’-(piperizin-1’’-
yl)phenyl)prop-2-en-1-one) was found to inhibit both drug transport proteins and may 
be a useful starting point for the design of dual inhibitors of transport proteins. 
Thus, the contribution of the basic functionality varied according to the type of 
activity being assessed. Antiproliferative and antibacterial properties were less 
influenced by the presence of the basic functionality. In the case of the inhibition of 
Pgp and BCRP, the basic group influenced the type of transporter that was inhibited. 
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